Argenx Se ARGX
NASDAQ ARGX
$1,033.15 -20.31 (-1.93%)
At close: Sep 4, 2026 · 4:00 PM EDT

Argenx Se (ARGX) Retained Earnings (2015 - 2026)

Argenx Se's (ARGX) quarterly Retained Earnings came in at $558.0 million in Q2 2026, up 100.05% on a YoY basis from $278.9 million in Q2 2025, and up 299.29% quarter-over-quarter from -$280.0 million in Q4 2025.

Analysis

Argenx Se (ARGX) Retained Earnings (2015 - 2026) Analysis & Trends

Argenx Se (ARGX) has reported Retained Earnings for 12 consecutive years, with $558.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Retained Earnings rose 100.05% year-over-year to $558.0 million; the trailing twelve-month figure through Jun 2026 stood at $558.0 million (up 100.05% YoY), and the FY2025 full-year result was -$280.0 million, up 99.98% from the prior year.
  • Retained Earnings rose to $558.0 million in Q2 2026 per ARGX's latest filing, from -$280.0 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $558.0 million in Q2 2026 and bottomed at -$2109.8 billion in Q4 2022.
  • Historically, Retained Earnings has averaged -$538.6 billion across 5 years, with a median of -$2.4 billion in 2023.
  • The sharpest annual moves came in 2024 and 2026: Retained Earnings plunged 65259.92% in 2024, then jumped 100.05% in 2026.
  • Over 5 years, Retained Earnings stood at -$2109.8 billion in 2022, then surged by 99.89% to -$2.4 billion in 2023, then slumped by 65259.92% to -$1571.8 billion in 2024, then surged by 99.98% to -$280.0 million in 2025, then jumped by 299.29% to $558.0 million in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered $558.0 million, -$280.0 million, and -$1157.0 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn -22.28 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 9.53 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 15.69 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 37.62 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 558.00 Mn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 5.10 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn -6.33 Bn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 20.97 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 6.57 Bn
10 BioNTech SE 26.24 Bn 12.58 Bn 10.00 Mn 19.31 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 558.00 Mn
Dec 31, 2025 -280.00 Mn
Jun 30, 2025 -1,156.98 Bn
Dec 31, 2024 -1,571.80 Bn
Jun 30, 2024 -2.44 Bn
Dec 31, 2023 -2.40 Bn
Jun 30, 2023 -2.23 Bn
Dec 31, 2022 -2,109.79 Bn
Jun 30, 2022 -1.84 Bn
Dec 31, 2021 -1,400.20 Bn
Jun 30, 2021 -928.76 Mn
Dec 31, 2020 -1,027.15 Bn
Jun 30, 2020 -592.81 Mn
Dec 31, 2019 -368.12 Mn
Jun 30, 2019 -241.27 Mn
Dec 31, 2018 -193.58 Mn
Jun 30, 2018 -146.84 Mn
Dec 31, 2017 -118.41 Mn
Jun 30, 2017 -88.72 Mn
Dec 31, 2016 -78.27 Mn